betamethasone-17,21-dipropionate has been researched along with Lichen Planus, Oral in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agbo-Godeau, S; Bernard, P; Boralevi, F; Francès, C; Fricain, JC; Le Gouge, A; Leducq, S; Pascal, F; Passeron, T; Samimi, M; Vaillant, L | 1 |
| Alajbeg, I; Brailo, V; Rogulj, AA; Škrinjar, I; Vučićević-Boras, V; Z Alajbeg, I; Žužul, I | 1 |
| Alajbeg, I; Andabak Rogulj, A; Brkić, D; Džanić, E | 1 |
3 trial(s) available for betamethasone-17,21-dipropionate and Lichen Planus, Oral
| Article | Year |
|---|---|
Topical rapamycin versus betamethasone dipropionate ointment for treating oral erosive lichen planus: a randomized, double-blind, controlled study.
Topics: Administration, Topical; Betamethasone; Double-Blind Method; Humans; Lichen Planus, Oral; Neoplasm Recurrence, Local; Ointments; Psoriasis; Sirolimus; Treatment Outcome | 2020 |
Topical NAVS naphthalan for the treatment of oral lichen planus and recurrent aphthous stomatitis: A double blind, randomized, parallel group study.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Female; Humans; Lichen Planus, Oral; Male; Middle Aged; Naphthalenes; Quality of Life; Stomatitis, Aphthous | 2021 |
NAVS naphthalan for the treatment of oral mucosal diseases--a pilot study.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Betamethasone; Double-Blind Method; Female; Humans; Lichen Planus, Oral; Male; Naphthalenes; Ointments; Pain Measurement; Pilot Projects; Recurrence; Severity of Illness Index; Stomatitis, Aphthous; Treatment Outcome | 2014 |